ELISA results clarified the expression levels of the two pathways, CDC25B and NF-kB, in which their level increased in the case of the psoriasis sample, till CDC25B reached 3.4 and NF-kB reached 2.1, which is more than the normal range, that is 1. Here, NFKB1 is linked to psoriasis.